Lafora disease (LD) is a fatal neurodegenerative disorder caused mostly by mutations in either of two genes encoding laforin and malin. LD is characterized by accumulation of a poorly branched form of glycogen in the cytoplasm of neurons and other cells. We previously reported dysfunctional mitochondria in different LD models. Now, using mitochondrial uncouplers and respiratory chain inhibitors, we have investigated with human fibroblasts a possible alteration in the selective degradation of damaged mitochondria (mitophagy) in LD. By flow cytometry of MitoTracker-labelled cells and measuring the levels of various mitochondrial proteins by western blot, we found in LD fibroblasts a partial impairment in the increased mitochondrial degradation produced by these treatments. In addition, colocalization of mitochondrial and lysosomal markers decreased in LD fibroblasts. All these results are consistent with a partial impairment in the induced autophagic degradation of dysfunctional mitochondria in LD fibroblasts. However, canonical recruitment of Parkin to mitochondria under these conditions remained unaffected in LD fibroblasts, and also in SH-SY5Y cells after malin and laforin overexpression. Neither mitochondrial localization nor protein levels of Bcl-2-like protein 13, another component of the mitophagic machinery that operates under these conditions, were affected in LD fibroblasts. In contrast, although these treatments raised autophagy in both control and LD fibroblasts, this enhanced autophagy was clearly lower in the latter cells. Therefore, the autophagic degradation of altered mitochondria is impaired in LD, which is due to a partial defect in the autophagic response and not in the canonical mitophagy signalling pathways.
Introduction
Lafora progressive myoclonus epilepsy, also called Lafora disease (LD, OMIM 254780), is a rare, fatal, autosomal and recessive neurodegenerative disorder. It starts between the ages of 8 and 18 years with tonicclonic seizures, myoclonus, absences, drop attacks and visual hallucinations, which rapidly drive the patient Abbreviations BCL2L13, Bcl-2-like protein 13; BSA, bovine serum albumin; CCCP, carbonyl cyanide m-chlorophenylhydrazone; COX IV, cytochrome c oxidase, subunit 4; CYTC, cytochrome C; DAPI, 4 0 ,6-diamidino-2-phenylindole; FCCP, p-rifluoromethoxyphenylhydrazone; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GFP, green fluorescent protein; LB, Lafora bodies; GDH, glutamate dehydrogenase; LAMP, lysosome-associated membrane protein; LD, Lafora disease; OPA1, mitochondrial dynamin like GTPase; PDH, pyruvate dehydrogenase; PMSF, phenylmethylsulfonyl fluoride; PBS, phosphate buffered saline; SDHA, subunit A of the succinate dehydrogenase complex; TOM, translocase of outer membrane; VDAC, voltage-dependent anion-selective channel.
to a cognitive decline with dementia, apraxia, aphasia and visual loss. Finally, death follows, usually about 10 years after onset of the first symptoms of the disease [1, 2] . LD occurs worldwide, but most commonly in southern Europe, northern Africa, India and the Middle East. A hallmark of LD is the presence of distinctive inclusions called Lafora bodies (LBs, see [3] for a review). They are present in the cytoplasm of brain neurons, but also in cells from different peripheral tissues, especially those with high glucose metabolism such as liver, heart and skeletal muscle. LBs are mainly made up of polyglucosans, which are an abnormal, heavily phosphorylated and poorly branched form of glycogen that resembles amylopectin [4] . Although there is also evidence of a third minor locus [5] , LD is caused mainly (more than 90% of all cases) by mutations in either of two different genes. The first, EPM2A [6] , encodes a 38 kDa (331 amino acids) dual-specificity phosphatase called laforin, which is the most frequently mutated protein in LD. The second, EPM2B [7] , encodes a 42 kDa (395 amino acids) RING type E3-ubiquitin ligase called malin, which polyubiquitinates different substrates, such as laforin [8] , glycogen synthase [9] , glycogen debranching enzyme [10] , protein targeting to glycogen [11] and AMP-activated protein kinase [12] .
It has been found that laforin and malin form a complex, which has been suggested to degrade proteins involved in the regulation of glycogen metabolism [9] , and to also clear misfolded proteins via the ubiquitinproteasome system [13] . Laforin, through its capacity to dephosphorylate polysaccharides [14] , can prevent the excessive phosphorylation of glycogen that leads to its aggregation in the form of polyglucosans [15] . Therefore, LD could be caused by the accumulation of misfolded proteins and/or could result from an error of carbohydrate metabolism. In any case, patients with mutated laforin or malin are clinically indistinguishable and both proteins appear to be involved in a same pathway that produces the disease. However, the pathogenic mechanism of LD remains unclear despite extensive studies.
Mitochondrial dysfunction has been frequently associated with several neurodegenerative disorders because of the high dependence of neurons on oxidative energy metabolism [16] . In fact, our own studies conducted in various LD models have described mitochondrial alterations, including decreases in both mitochondrial membrane potential and ATP levels, as well as oxidative stress due to increased ROS production and aggravated by an impaired antioxidant response [17, 18] . Here, to further define the sequence of alterations in LD, we tested if a defect in the degradation of dysfunctional mitochondria exists. We investigated if the selective autophagic degradation of altered mitochondria (i.e. mitophagy) is affected in human malinor laforin-deficient fibroblasts after treating the cells with various uncouplers and inhibitors that alter mitochondrial function while leaving intact other organelles, such as peroxisomes [19] . To this end, we used first, with similar results, carbonyl cyanide m-chlorophenylhydrazone (CCCP) and p-trifluoromethoxyphenylhydrazone (FCCP). Although CCCP and FCCP are the most widely used compounds to study mitophagy, it has been described that, besides causing mitochondrial membrane depolarization, they may also depolarize the cell membrane [20, 21] . Therefore in these studies, we also used a combination of oligomycin, which inhibits mitochondrial complex V (ATP synthase), and antimycin A, which inhibits mitochondrial complex III [22] . We found that the selective autophagic degradation of altered mitochondria induced by any of these poisons was partially impaired in both laforin-and malin-deficient fibroblasts and that this is due to a general defect in the autophagic mechanism and not in the canonical Parkin-dependent signalling to mitophagy of defective mitochondria.
Results

Mitophagy is defective in fibroblasts from LD patients
We started these experiments analysing in human fibroblasts for the effects of CCCP, an uncoupler of mitochondrial oxidative phosphorylation, on mitochondrial morphology. As expected [23] , this treatment changed the interconnected tubular network of mitochondria observed in the human fibroblasts labelled with MitoTracker Red (Fig. 1A) so that its appearance became more fragmented (Fig. 1B) . This is indicative of the specific alteration in mitochondrial function induced by this reagent. Similar results were obtained using another mitochondrial uncoupling reagent, FCCP [21] (Fig. 1C) , or a combination of the respiratory chain inhibitors oligomycin and antimycin A [22] (Fig. 1D ). All the following experiments were carried out by treating cells independently with all these reagents, and essentially the same results were obtained.
Next, we assessed the selective degradation of altered mitochondria (mitophagy) in LD fibroblasts after the above mentioned treatments. A widely employed method to analyse whole mitochondrial degradation is to measure, by flow cytometry, the decrease in the fluorescence intensity of MitoTracker Red-stained cells [24, 25] . As shown in Fig. 2 , we incubated the fibroblasts from the controls (A-C), laforin-(D-F) and malin-deficient (G-I) patients with MitoTracker Red for 30 min at 37°C and measured, by flow cytometry, the fluorescence intensity of the probe after 18 h of growth in the presence (Fig. 2B , E and H), or not ( Fig. 2A, D and G), of 10 lM CCCP, or as a control, with 10 lM CCCP plus 10 mM 3-methyladenine (Fig. 2C, F and I ), an inhibitor of autophagy [26, 27] . Since CCCP has been described to not affect the mitochondrial retention of the MitoTracker stain [24] , loss of fluorescence in the presence of this compound should correspond to degradation of mitochondria. We found (Fig. 2J ) that the decrease in MitoTracker Red fluorescence after CCCP treatment was significantly lower in the fibroblasts from LD patients (reduction of 33.7 AE 1.6% and 33.1 AE 2.1%, respectively, in laforin-and malin-deficient fibroblasts) than in their controls (reduction of 47.7 AE 1.9%). These results also showed that the specific degradation of damaged mitochondria was reduced to an almost identical extent in the laforin-and malin-deficient fibroblasts.
Similar results were obtained with oligomycin plus antimycin A (Fig. 2K ) or with FCCP (data not shown). Finally as expected, the decrease in fluorescence produced by CCCP, FCCP and oligomycin plus antimycin A was strongly abolished when 3-methyladenine was added in combination with these reagents (Fig. 2) .
To confirm these results we investigated, by western blot, the degradation of proteins from different mitochondrial compartments, induced in various cells by all these treatments. The following mitochondrial proteins were herein analysed in the treated and untreated cells: the voltage-dependent anion-selective channel 1 (VDAC1) from the outer membrane, dynamin like GTPase OPA1 and subunit A of the succinate dehydrogenase complex (SDHA) from the inner membrane and glutamate dehydrogenase (GDH) and pyruvate dehydrogenase (PDH) from the mitochondrial matrix. To discard a possible defect in the import of mitochondrial proteins encoded by the nuclear genome, we also analysed a protein encoded by the mitochondrial genome, namely cytochrome c oxidase, subunit 4 (COX IV) from the inner membrane. In these experiments, the cells were incubated in full medium as before (Fig. 2) , and also in a starvation medium (KH) to increase the autophagic response. In addition, and because the treatments employed here do not affect peroxisomes [19] , catalase was also included as a negative control and tubulin was used as loading control. decreased after 18 h of CCCP treatment, independently of whether they were cultured during the last 4 h in full (Fig. 3A ,C) or in KH (Fig. 3B,D) media. However, this decrease was always less severe in laforin-and malin-deficient fibroblasts compared to controls. In contrast and under the same conditions, no drop in the levels of the peroxisomal protein catalase was found. This indicates that the observed decrease in the levels of the mitochondrial proteins produced by the CCCP treatment was not due to a general degradation of all cell proteins, but to a specific degradation of the mitochondria altered by these by CCCP or OA is also indicated in percentage. Differences were found to be statistically significant at ***P < 0.0001. No significant differences were observed between laforin-and malin-deficient fibroblasts.
treatments and of their proteins. Similar results were obtained incubating the cells with FCCP (data not shown) or oligomycin plus antimycin A (Fig. 4) . In summary, the MitoTracker Red and the western blot results well agree and indicate that: (a) the degradation of the altered mitochondria induced by all these treatments is partially impaired in the laforin-and malin-deficient fibroblasts, and (b) this impairment occurs to a similar extent in both types of LD fibroblasts.
Another way to analyse mitophagy is to investigate, by fluorescence microscopy, the colocalization of mitochondria and lysosomes, after inhibition of lysosomal activity to prevent the degradation of mitochondria within lysosomes (Fig. 5) . To stain the mitochondria and lysosomes we first used MitoTracker Red and anti-LAMP2 antibody (a marker of the lysosomal membrane) respectively. When the cells were treated with CCCP, we observed a significant reduction (Fig. 5E ) in the colocalization of both stains in fibroblasts from the LD patients (Fig. 5C ,D) compared to their controls (Fig. 5A,B) . Moreover, no differences were found between the laforin-and malin-deficient fibroblasts in this colocalization. Similar results were obtained with FCCP (data not shown) or after oligomycin plus antimycin A treatment (Fig. 6) , and also when a different mitochondrial marker (anti-TOM20 antibody) was used. These results once again support the notion that in LD fibroblasts, the selective degradation of altered mitochondria by lysosomes (mitophagy) is impaired to a great extent. Therefore, we next attempted to determine the mechanisms by which this impairment occurs.
Recruitment of Parkin to altered mitochondria is not affected in fibroblasts from LD patients or in SH-SY5Y cells after laforin and malin overexpression
As LD fibroblasts would appear to be unable to properly degrade dysfunctional mitochondria after the CCCP, FCCP or oligomycin plus antimycin A treatments, we first investigated if mitophagy signalling is defective in LD fibroblasts. The E3-ubiquitin ligase Parkin participates in the canonical and main mechanism to selectively recognize and remove damaged mitochondria by macroautophagy, and it has been shown that the mitochondria damaged by a CCCP treatment recruit Parkin [28] . Therefore, we investigated a possible defect in LD fibroblasts in the recognition of the altered mitochondria by Parkin. As shown in Fig. 7A , the treatment of the different fibroblasts with CCCP produced a strong recruitment of EGFPParkin to mitochondria, identified with an anti-CYTC antibody (see the merge of the fluorescent images after the CCCP treatment). The translocation of EGFP-Parkin to mitochondria occurred in both types of LD fibroblasts, and showed no significant differences from the control fibroblasts (Fig. 7B) . The same results were obtained after treatment with oligomycin plus antimycin A or with FCCP (data not shown). Therefore, it would appear that in the fibroblasts from LD patients lacking laforin or malin, Parkin is normally recruited to dysfunctional mitochondria.
We also used neuroblastoma SH-SY5Y cells to check the effects of laforin and malin on the localization of Parkin upon these treatments. In these cells we found that silencing of laforin using siRNA (Fig. 8B ) or overexpressing laforin and malin ( Fig. 8C) did not modify the Parkin translocation induced by CCCP (Fig. 8A) . Moreover, after overexpression of laforin and malin, none of these proteins colocalized with mitochondria in CCCP-treated or untreated cells (Fig. 9 ). Therefore, it was not possible to explain the alteration observed in the LD fibroblasts of the mitochondrial degradation induced by CCCP and by the other treatments with a defect in the recruitment and recognition of the damaged mitochondria by Parkin. Although this is the main mechanism of mitophagy signalling under the conditions used in these experiments, we also analysed an alternative pathway of mitophagy that involves BCL2L13 (Fig. 10 ). Once again, we obtained the same results with the control and LD fibroblasts, treated or not with CCCP. Therefore, the canonical mitophagy signalling pathway that operates under the conditions used herein is not affected in the fibroblasts from LD patients.
The defective degradation of altered mitochondria in fibroblasts from LD patients can be explained by a partial impairment in autophagosome formation
Essentially and in short, the results presented so far indicate reduced lysosomal degradation of mitochondria and their proteins in LD fibroblasts which cannot be explained by defects in canonical Parkin-and BCL2L13-dependent mitophagy. Therefore, we assessed if the second step in the mitophagy of the Parkin-signalled mitochondria, namely the autophagic engulfment and degradation of the altered mitochondria, was affected in LD fibroblasts after the different treatments (CCCP, FCCP or oligomycin plus antimycin A) herein employed.
Although there are various procedures to monitor autophagy, it is widely accepted that changes in the levels of lipidated LC3 (LC3-II) in the presence of lysosomal inhibitors accurately reflect alterations in autophagosome formation [29, 30] . Therefore, the control and LD fibroblasts were incubated, or not, with CCCP, FCCP or oligomycin plus antimycin A for 18 h as before (in full and KH media) and lysosomal inhibitors were added in the last 2 h of the treatments. As shown in Fig. 11 (for CCCP treatment) and in the Fig. 12 (for oligomycin plus antimycin A treatment), these treatments strongly increased the LC3-II levels in the fibroblasts incubated both in full (Figs 11A,C and 12A,C) and in KH (Figs 11B,D, and 12B,D) media. These results agree with the previously described induction of macroautophagy by CCCP [31] . However, in the case of LD fibroblasts grown either in full or KH media, we observed lower LC3-II levels under all conditions, compared to the corresponding control fibroblasts (Figs 11 and 12 ). These results were also supported by immunofluorescence studies using anti-LC3 and counting the number of LC3 puncta per cell, which are believed to correspond to the number of autophagosomes [29] . These numbers markedly increased in the presence of CCCP in full (Fig. 13A ,C) or in KH (Fig. 13B,D) media, but they were always lower in laforin-and malindeficient fibroblasts. Similar results were obtained using FCCP or a combination of oligomycin plus antimycin A (data not shown). Note that in all these experiments, no significant differences in LC3-II levels were seen between the laforin-or malin-deficient cells, which indicates that the defect in autophagy, like the impairment in the degradation of mitochondria and their proteins (see Figs 2-6), occurs to the same extent in EPM2A and in EPM2B mutated fibroblasts. Therefore, all these results suggest that a defect in the formation of autophagic vacuoles is responsible for the reduced mitophagy observed in the laforin-and malin-deficient fibroblasts.
Discussion
Lafora disease (LD) is caused by mutations in either EPM2A or EPM2B genes, which encode, respectively, laforin, a dual-specificity phosphatase and malin, an E3 ubiquitin ligase [2] . Patients carrying mutations in either EPM2A or EPM2B are phenotypically indistinguishable and it has been also described that laforin and malin form a complex [9, 11] . Therefore, both proteins may participate in a common biochemical process. However, in spite of much work, the detailed mechanisms whereby these proteins are involved in LD are still unknown and more data are necessary to fully understand the causes of this pathology. Several alterations in mitochondrial functions have been previously associated to different muscular and neurodegenerative disorders [32] . In LD, we have already described in this disease defects in mitochondrial functions, including decreases in mitochondrial membrane potential and in ATP levels, a higher oxidative stress due to both an increase in ROS production and a dysregulation of the antioxidant enzyme response [17, 18] . To prevent defective mitochondria from accumulating, cells have developed a mechanism to eliminate excessive or dysfunctional mitochondria by a selective autophagic mechanism called mitophagy [33] , which has emerged in the last years as a major player in the pathogenesis of neurodegenerative disorders and of many other diseases [34] . Therefore, in this work we have investigated whether mitophagy was impaired in LD. To this end, we treated primary fibroblasts from LD patients carrying mutations in either EPM2A or EPM2B genes with mitochondrial uncouplers or respiratory chain inhibitors to alter mitochondrial functions. Mitochondrial degradation was tested by a standard flow cytometric approach with cells labelled with MitoTracker Red, and also by using western blot to measure the levels of specific mitochondrial proteins from different mitochondrial compartments: OPA1, SDHA, GDH, PDH, VDAC1 and COX IV. We observed that, compared to their controls, in both the laforin-and malin-deficient fibroblasts, treatments with CCCP, FCCP or a combination of oligomycin plus antimycin A, led to a Fig. 3 . Degradation of mitochondrial proteins in control and in LD fibroblasts in the presence or absence of CCCP. Fibroblasts from controls (C-1 and C-2) and patients with LD, laforin-(L-1 and L-2) and malin-deficient (M-1), were incubated for 18 h in full medium without or with (+CCCP) 10 lM CCCP, as indicated. For the last 4 h, fibroblasts were incubated in full (A) or in KH (B) media with and without CCCP as corresponds. Cellular extracts (75 lg protein) were analysed by western blot using specific antibodies towards the following mitochondrial proteins: OPA1, SDHA, GDH, PDH, VDAC1 and COX IV. Antibodies towards catalase and tubulin were also used as negative and loading controls respectively. Notice in the OPA1 blots that CCCP induces a proteolytic processing of the heavy molecular weight band leading to its disappearance, in agreement with results from others [49] . The histograms (C and D) show the densitometric quantifications of the band intensities of the indicated proteins relative to tubulin from control (CTR: mean values from C-1 and C-2 cells), laforin-(Laforin-: mean values from L-1 and L-2 cells) and malin-deficient (Malin-: M-1 cells) fibroblasts treated (+CCCP, green bars) or not (-CCCP, red bars) as above and incubated during the last 4 h of the 18-h incubation in full (C) or in KH (D) media. Results are the mean and standard deviation from three independent experiments and are shown as percentage of the highest control value of each protein ratio. The difference in the levels of the corresponding proteins produced by the CCCP treatment in the various cells is also indicated as percentage. Differences were found to be statistically significant at *P < 0.01, **P < 0.001 and ***P < 0.0001. No significant differences were observed between laforin-and malin-deficient fibroblasts. . Experiments were performed in duplicate, analysing 40 cells for each cell line. Differences were found to be statistically significant at ***P < 0.0001. No significant differences were observed between laforin-and malin-deficient fibroblasts. The difference in the levels of the corresponding proteins produced by the oligomycin plus antimycin A treatment in the various cells is also indicated as percentage. Differences were found to be statistically significant at **P < 0.001 and ***P < 0.0001. No significant differences were observed between laforin-and malin-deficient fibroblasts.
defective degradation of whole mitochondria and their proteins. This defect also occurred under starvation conditions (growth in KH medium), which were used to increase autophagy and to facilitate the clearance of damaged mitochondria. Mitophagy can also be assessed analysing the colocalization of lysosomal and mitochondrial markers by fluorescence microscopy [35] . With this technique we found increased colocalization of both markers upon CCCP, FCCP or oligomycin plus antimycin A treatment in the control and LD fibroblasts. However, this colocalization was clearly lower in laforin-and malin-deficient fibroblasts, which once again supports the existence of a defect in mitophagy associated with LD fibroblasts. Since laforin and malin form a functional complex and no substantial phenotypic differences have been found in patients carrying mutations in either of both genes, it is interesting that this mitophagy defect occurs to a similar extent in fibroblasts from patients carrying mutations in either of the two genes implicated in LD.
Although other mitophagy signalling pathways may exist (for reviews see e.g. [36, 37] ), canonical mitophagy is regulated by two proteins, mitochondrial kinase PINK1 and the E3-ubiquitin ligase Parkin. The pathway starts when PINK1 accumulates on defective mitochondria and triggers the translocation of Parkin to them, which thus allows the recognition of dysfunctional mitochondria by the autophagic machinery [38] . We herein found that this translocation of Parkin from the cytosol to mitochondria induced by CCCP, FCCP or oligomycin plus antimycin A was not altered in the laforin-and malin-deficient fibroblasts. Also, the overexpression of laforin and malin in SH-SY5Y cells did not affect the translocation of Parkin that occurred upon these treatments, which indicates again that laforin and malin do not play a major role in the regulation of canonical mitophagy signalling pathway. Our results do not support a recent publication which has suggested that translocation of Parkin to mitochondria upon CCCP treatment was dramatically reduced in Cell nuclei were stained with DAPI and the fourth column shows the corresponding merge images. A representative image is presented in each case (A). Bar: 10 lm. To test the laforin silencing, SH-SY5Y cells were transfected with pGFP-siRNA-control and pGFP-siRNA-laforin plasmids. After 24 h of transfection, cellular extracts were prepared and the levels of endogenous laforin were analysed by western blot using anti-laforin antibody and also anti-tubulin antibody as loading control (B). We found around 60% reduction in the levels of endogenous laforin. To check the overexpression levels, cellular extracts were prepared and the levels of laforin and malin were analysed by western blot using antilaforin and anti-HA antibodies respectively (C). Tubulin was used as loading control. No differences were found in cells treated or not with CCCP. mouse fibroblasts from Epm2aÀ/À and Epm2bÀ/À mice [39] . Perhaps variations in the models employed could account for this difference. Moreover, compared to the controls, nor was an alternative mitophagic player such as BCL2L13 [37] , altered in LD fibroblasts.
If mitophagy signalling is not altered in LD, a defect in the other component of the mitophagy machinery, autophagy, may explain the decreased degradation of the altered mitochondria in LD fibroblasts. In fact, we have previously found an impairment of autophagy in laforin-deficient fibroblasts from human patients and in mouse embryonic fibroblasts and in various tissues from laforin knockout mice (Epm2aÀ/À) [40] . A similar defect in autophagy was later described in malindeficient mice (Epm2bÀ/À) [41] and in other laforin and malin knockout mice [42, 43] . However, it has been postulated that the impairment in autophagy in LD could be secondary to the accumulation of glycogen [42] , and more recently other groups have even questioned the existence of a general autophagic defect in LD [44, 45] . Here, we found that although an increase in the autophagic response took place, as expected [31] , after treating the cells with CCCP, FCCP or oligomycin plus antimycin A, as well as under starvation conditions (growth in KH medium), the LC3-II levels were always clearly lower in the fibroblasts from LD patients. Moreover, since the experiments to measure LC3-II levels were performed in the presence of lysosomal inhibitors, we can conclude that the reduced autophagic response of LD fibroblasts is due to a defect in autophagosome formation. This supports and extends our previous results on the existence of a defective autophagy in different LD models [40, 41] . Interestingly, the deficiency in the autophagic degradation of altered mitochondria described herein was about the same in the laforinand malin-deficient fibroblasts. This finding indicates a common defective mechanism, which results in the effect could be that as LBs contain in addition to polyglucosans, advanced glycation end-products, polyubiquitinated proteins, proteasome subunits and autophagy related proteins, such as p62, the sequestration of p62 and other proteins involved in autophagy in LBs might lead to autophagy dysfunction. By blocking glycogen synthesis, LBs would not be formed and autophagy could thus be recovered. . All values are means and standard deviations of five independent experiments. Differences were found to be statistically significant at *P < 0.01, **P < 0.001 and ***P < 0.0001. No significant differences were observed between laforin-and malin-deficient fibroblasts. Fig. 12 . Effect of oligomycin plus antimycin A treatment on the LC3-II levels in control and in LD fibroblasts. Control (C-1 and C-2), laforindeficient (L-1 and L-2) and malin-deficient (M-1) fibroblasts were incubated in full medium without (-OA) or with (+OA) 10 lM oligomycin plus 1 lM antimycin A for 18 h. For the last 2 h of treatment, fibroblasts were incubated in full (A) or in KH (B) media with lysosomal inhibitors (20 mM ammonium chloride and 100 lM leupeptin). Cellular extracts (75 lg protein) from the different samples were analysed by western blot using anti-LC3 and anti-actin antibodies. Representative immunoblots are shown. The intensity of the bands was assessed by densitometry and the LC3-II values were normalized to those of actin in the same lanes (C and D, for full and KH media, respectively) in control (CTR, red bars), laforin-deficient (Laforin-, green bars) and malin-deficient (Malin-, blue bars) fibroblasts. In the histograms, the results are expressed as percentage of the respective highest control value. All values correspond to the means and standard deviations of five independent experiments. Differences were found to be statistically significant at **P < 0.001, ***P < 0.0001. No significant differences were observed between laforin-and malin-deficient fibroblasts. . Differences were found to be statistically significant at *P < 0.01 and ***P < 0.0001. No significant differences were observed between laforin-and malin-deficient fibroblasts.
In summary, here we show lower mitophagy in LD fibroblasts, which is not due to defects in the canonical mitophagy signalling pathway, but is owing rather to a partial impairment in the formation of autophagic vacuoles in these cells. As a result, dysfunctional mitochondria accumulate in cells, which may notably contribute to the pathology.
Experimental procedures
Chemicals, antibodies and other reagents . Horseradish peroxidase-labelled secondary antibodies were from Sigma Chemical Co. To detect glutamate dehydrogenase (GDH), a monoclonal antibody obtained in our laboratory was used [46] . All other reagents employed in this study were of analytical grade.
Cell culture and treatments
Lafora disease fibroblasts were obtained from three patients. Two of them contained mutations in the laforin gene (EPM2A) (L-1: Y112X/N163D; L-2: R241X/R241X) and the third, which was obtained from the Coriell Institute for Medical Research (Camden, NJ, USA), was mutated in the malin gene (EPM2B) (M-1: P129H/P129H). All patients presented the clinical features of LD. Control fibroblasts (C-1 and C-2) were matched by sex and age with LD fibroblasts and all experiments were performed at passage number 10-14 to avoid culture aging effects. Cell growth and viability were performed by counting the cells in a haemocytometer chamber and using the trypan blue exclusion test.
Fibroblasts were grown at 37°C in a humidified atmosphere at 5% (v/v) CO 2 
4).
When indicated, cells growing at 37°C in full medium were treated with either 10 lM CCCP, 10 lM FCCP or 10 lM oligomycin plus 1 lM antimycin A for the indicated times. As lysosomal inhibitors, either 100 lM leupeptin plus 20 mM NH 4 Cl or 100 lM leupeptin plus 1 lM pepstatin A were used with similar results.
SH-SY5Y human neuroblastoma cells were grown as above but in DMEM/F12 supplemented with 100 UÁmL À1 penicillin, 100 lgÁmL À1 streptomycin, 2 mM L-glutamine and 10% inactivated foetal bovine serum. Silencing of laforin with siRNA and transfections with Myc-laforin and HA-malin in SH-SY5Y cells were carried out as previously described [47] .
Flow cytometry analyses
Cells were incubated in full medium with 100 nM MitoTracker Red for 30 min at 37°C and, after washing with PBS, cells were incubated for 18 h at 37°C with the mitochondrial uncouplers or inhibitors that affect mitochondrial function. Where indicated, 3-methyladenine was added at 10 mM as an autophagy control. Cells were detached with trypsin-EDTA, washed three times and resuspended in PBS (10 6 cellsÁmL À1 ) at 4°C. The emitted red fluorescence (620 AE 20 nm band-pass filter) was measured by flow cytometry. In each experiment, 10 000 cells were collected and analysed using a Cytomics FC500 Flow cytometer (Beckman Coulter, Madrid, Spain).
Fluorescence microscopy
Cells were cultured on coverslips and stained with 100 nM MitoTracker Red for 30 min at 37°C. Then, cells were rinsed with phosphate buffered saline (PBS), incubated in full medium for 18 h with or without the mitochondrial uncouplers or inhibitors that affect mitochondrial function, fixed with 4% paraformaldehyde in PBS for 10 min at room temperature, washed three times with PBS and mounted using FluorSave reagent. For colocalization studies of mitochondria and lysosomes or for LC3 detection, cells were incubated as above, except that lysosomal inhibitors (see the Cell culture and treatments section) were added in the last 2 h of the incubation. Cells were then fixed as above and quenched with 75 mM NH 4 Cl and 20 mM glycine for 10 min, permeabilized with Triton X-100 (0.3%, v/v in PBS) for 10 min and blocked with 1% BSA and 0.1% Triton X-100 in PBS for 30 min. Then, cells were incubated overnight at 4°C with the corresponding primary antibodies [anti-BCL2L13 (dilution 1/300), anti-CYTC (dilution 1/300), anti-HA (dilution 1/300), anti-LAMP2 (dilution 1 : 100), antiMyc (dilution 1/300), anti-TOM20 (dilution 1/300), anti-LC3 (dilution 1/100)]. Coverslips were washed four times with PBS and incubated with the corresponding Alexa Fluor-conjugated secondary antibody for 1 h at room temperature. After extensively washing, the coverslips were mounted using FluorSave reagent. In some experiments, cells were also incubated with DAPI (1 lgÁmL
À1
) for 10 min at room temperature. Preparations were observed in a fluorescence microscope Leica DM6000 B and images were acquired with a Leica TCS SP8 HyVolutionII Laser Scanning Inverted Confocal Microscope. Quantification of colocalizations was carried out using METAMORPH software version 7.0 (Molecular Devices, Barcelona, Spain).
Western blot analyses
Western blot was carried out essentially as described [48] . Briefly, cells were collected and lysed in RIPA buffer (150 mM NaCl, 1% Nonidet-P40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate and 50 mM Tris-HCl, pH 8.0, containing 1 mM PMSF and 100 lM leupeptin) at 4°C. Samples were analysed on 12% or 15% SDS/PAGE and proteins were transferred to PVDF membranes (Millipore). Membranes were blocked with 5% (w/v) nonfat milk in Tris-buffered saline (TBS: 50 mM Tris-HCl, 150 mM NaCl, pH 7.4) for 1 h at room temperature and incubated overnight at 4°C with the corresponding primary antibodies. Then, membranes were probed with the suitable secondary antibodies for 1 h at room temperature. Signals were visualized using Lumi-Light Western Blotting Substrate (Roche Applied Science) or ECL Prime Western Blotting Detection Reagent (GE Healthcare, Barcelona, Spain) on Medical X-Ray Film (Kodak). Protein concentration was measured by a modification, with sodium deoxycholate, of the Lowry procedure, using BSA as standard. Protein bands were quantified by densitometric analysis using the IMAGE QUANT ECL (GE Healthcare) software.
Statistical analyses
Results are shown as means and standard deviations. Differences between paired of samples were analysed by two-tailed Student's t-tests using GRAPH PAD PRISM version 5.0 statistical software (La Jolla, CA, USA). P values have been considered in all figures as: *P < 0.01, **P < 0.001 and ***P < 0.0001.
